177 related articles for article (PubMed ID: 24947588)
21. Managing HIV and Hodgkin lymphoma in the twenty-first century.
Aries J; Montoto S
Curr Hematol Malig Rep; 2014 Sep; 9(3):227-32. PubMed ID: 24906351
[TBL] [Abstract][Full Text] [Related]
22. The impact of HIV viral control on the incidence of HIV-associated anal cancer.
Chiao EY; Hartman CM; El-Serag HB; Giordano TP
J Acquir Immune Defic Syndr; 2013 Aug; 63(5):631-8. PubMed ID: 23614995
[TBL] [Abstract][Full Text] [Related]
23. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
24. Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era.
Martin-Iguacel R; Ahlström MG; Touma M; Engsig FN; Stærke NB; Stærkind M; Obel N; Rasmussen LD
J Infect; 2017 Sep; 75(3):263-273. PubMed ID: 28579301
[TBL] [Abstract][Full Text] [Related]
25. A case-control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda.
Mpunga T; Znaor A; Uwizeye FR; Uwase A; Munyanshongore C; Franceschi S; Clifford GM
Int J Cancer; 2018 Sep; 143(6):1348-1355. PubMed ID: 29663358
[TBL] [Abstract][Full Text] [Related]
26. Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4.
Fontas E; Kousignian I; Pradier C; Duvivier C; Poizot-Martin I; Durier C; Jarrousse B; Weiss L; Levy Y; Costagliola D;
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):206-14. PubMed ID: 19131886
[TBL] [Abstract][Full Text] [Related]
27. Excessive neurotoxicity with ABVD when combined with protease inhibitor-based antiretroviral therapy in the treatment of AIDS-related Hodgkin lymphoma.
Cheung MC; Hicks LK; Leitch HA
Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):E22-5. PubMed ID: 20371439
[TBL] [Abstract][Full Text] [Related]
28. Cumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veterans.
Kowalkowski MA; Day RS; Du XL; Chan W; Chiao EY
J Acquir Immune Defic Syndr; 2014 Oct; 67(2):204-11. PubMed ID: 25078536
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.
Biggar RJ; Jaffe ES; Goedert JJ; Chaturvedi A; Pfeiffer R; Engels EA
Blood; 2006 Dec; 108(12):3786-91. PubMed ID: 16917006
[TBL] [Abstract][Full Text] [Related]
30. A declining CD4 count and diagnosis of HIV-associated Hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis?
Gupta RK; Marks M; Edwards SG; Smith K; Fletcher K; Lee SM; Ramsay A; Copas AJ; Miller RF
PLoS One; 2014; 9(2):e87442. PubMed ID: 24504076
[TBL] [Abstract][Full Text] [Related]
31. Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan.
Ma WL; Liu WD; Sun HY; Sheng WH; Hsieh SM; Wu SJ; Hung CC
J Microbiol Immunol Infect; 2024 Jun; 57(3):426-436. PubMed ID: 38632022
[TBL] [Abstract][Full Text] [Related]
32. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.
Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP;
Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354
[TBL] [Abstract][Full Text] [Related]
33. Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
Scherrer AU; Böni J; Yerly S; Klimkait T; Aubert V; Furrer H; Calmy A; Cavassini M; Elzi L; Vernazza PL; Bernasconi E; Ledergerber B; Günthard HF;
PLoS One; 2012; 7(11):e50307. PubMed ID: 23189194
[TBL] [Abstract][Full Text] [Related]
34. Hodgkin lymphoma in HIV positive patients.
Mounier N; Spina M; Spano JP
Curr HIV Res; 2010 Mar; 8(2):141-6. PubMed ID: 20163350
[TBL] [Abstract][Full Text] [Related]
35. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA;
Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971
[TBL] [Abstract][Full Text] [Related]
36. Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.
Lacombe JM; Boue F; Grabar S; Viget N; Gazaignes S; Lascaux-Cametz AS; Pacanowski J; Partisani M; Launay O; Matheron S; Rosenthal E; Rouveix E; Tattevin P; de Truchis P; Costagliola D; Goedert JJ
AIDS; 2013 Feb; 27(4):635-43. PubMed ID: 23196937
[TBL] [Abstract][Full Text] [Related]
37. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
38. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients.
Kowalska JD; Kubicka J; Siwak E; Pulik P; Firląg-Burkacka E; Horban A;
AIDS Res Ther; 2016; 13():2. PubMed ID: 26744599
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for oropharynx cancer in a cohort of HIV-infected veterans.
Chew EY; Hartman CM; Richardson PA; Zevallos JP; Sikora AG; Kramer JR; Chiao EY
Oral Oncol; 2017 May; 68():60-66. PubMed ID: 28438295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
